Continued funding for the C.W. Bill Young Cell Transplantation Program. Increased funding to expand patient access to transplants. Increased medical research funding.
2026 · 3rd Quarter (July 1 - Sep 30)
NATIONAL MARROW DONOR PROGRAM
Filed by NATIONAL MARROW DONOR PROGRAM.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- Not reported
- Expenses
- $310,000.00
- Registrant
- NATIONAL MARROW DONOR PROGRAM
- Filing UUID
- 88def145-35fb-4dee-8eac-c3f7f990861d
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Donated bone marrow/cell transportation for life-saving transplant.
Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials.
Literal federal measure citations: H.R. 5160, S. 4109, H.R. 3521, S. 4440
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.